ASCT Tops CAR T-Cell Therapy for Relapsed LBCL in Complete Remission
December 10, 2023
Dr. Mikkael A. Sekeres is quoted in this article that discusses the risks and benefits of autologous stem cell transplant and CAR T-cell therapy for patients with relapsed large B-cell lymphoma (LBCL) in complete remission.